Grifols’ sales rose by 4.6% to Euros 2,742 million in 2013
Shareholders endorse Grifols’ Growth strategy
Grifols to acquire a Novartis diagnostics business unit for US$1,675 million
The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products available in your country, please select your country from the list at the top of the page.